NCT04251078View on ClinicalTrials.gov

Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripheral Blood Samples

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

June 1, 2025

Study Completion Date

June 30, 2025

Conditions
Myelodysplastic Syndromes
Trial Locations (1)

08916

RECRUITING

Josep Carreras Leukaemia Research Institute, Badalona

Sponsors

Collaborators (1)

Celgene
All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

Josep Carreras Leukaemia Research Institute

OTHER